Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Arch Therapeutics, Inc. (ARTH) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Form of Amendment No. 11 to the First Notes",
"Form of Amendment No. 11 to the Second Notes",
"Form of Amendment No. 6 to the Third Notes"
09/27/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: " "
08/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Arch Therapeutics, Inc. Amended and Restated 2023 Equity Incentive Plan"
08/04/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Form of Amendment No. 9 to the First Notes",
"Form of Amendment No. 9 to the Second Notes",
"Form of Amendment No. 4 to the Third Notes"
07/24/2023 8-K Quarterly results
07/13/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events  Interactiv...
07/07/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Form of Amendment No. 7 to the First Notes",
"Form of Amendment No. 7 to the Second Notes",
"Form of Amendment No. 2 to the Third Notes"
04/20/2023 8-K Quarterly results
03/16/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Form of Exchange Agreement",
"Form of Amendment No. 2 to the First Notes",
"Form of Amendment No. 2 to the Second Notes",
"Form of Amendment No. 3 to the First Notes",
"Form of Amendment No. 3 to the Second Notes",
"Form of Amendment No. 1 to Series 1 Notes",
"Form of Amendment No. 1 to Series 2 Notes"
03/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Press Release issued by Arch Therapeutics, Inc."
03/07/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
01/17/2023 8-K Quarterly results
12/02/2022 8-K Quarterly results
09/30/2022 8-K Quarterly results
08/16/2022 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: " "
07/08/2022 8-K Quarterly results
01/04/2022 8-K Quarterly results
12/08/2021 8-K Quarterly results
10/18/2021 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
10/01/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "[email protected]"
09/02/2021 8-K Quarterly results
08/11/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement, effective June 30, 2021, by and between Arch Therapeutics, Inc. and Dan M. Yrigoyen",
"First Amendment to Employment Agreement, effective August 9, 2021, by and between Arch Therapeutics, Inc. and Dan M. Yrigoyen"
05/03/2021 8-K Quarterly results
04/19/2021 8-K Quarterly results
02/12/2021 8-K Quarterly results
01/04/2021 8-K Quarterly results
12/31/2020 8-K Quarterly results
11/10/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amendment to Series J Warrant to Purchase Common Stock",
"Form of Convertible Notes",
"Press Release issued by Arch Therapeutics, Inc. on November 10, 2020",
"Press Release issued by Arch Therapeutics, Inc. on November 9, 2020"
08/11/2020 8-K Quarterly results
07/01/2020 8-K Quarterly results
06/05/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Amendment to Series D Warrants to Purchase Common Stock",
"Form of Series J Warrant",
"Form of Convertible Notes",
"Press Release issued by Arch Therapeutics, Inc. on June 5, 2020"
05/27/2020 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Amended and Restated Bylaws, as adopted on May 20, 2020",
"Marked Bylaws of Arch Therapeutics, Inc"
04/27/2020 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "PPP Note"
04/13/2020 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Press Release issued by Arch Therapeutics, Inc. on April 13, 2020"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy